Revefenacin (REV) improves health status and dyspnea regardless of baseline symptom status in chronic obstructive pulmonary disease (COPD): a post hoc analysis of phase 3 trials

G. Ferguson (Farmington Hills, United States of America), T. Siler (St. Charles, United States of America), D. Lombardi (South San Francisco, United States of America), G. Crater (South San Francisco, United States of America)

Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Session: COPD : inhaled corticosteroids, bronchodilators and eosinophils
Session type: E-poster session
Number: 3244
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Ferguson (Farmington Hills, United States of America), T. Siler (St. Charles, United States of America), D. Lombardi (South San Francisco, United States of America), G. Crater (South San Francisco, United States of America). Revefenacin (REV) improves health status and dyspnea regardless of baseline symptom status in chronic obstructive pulmonary disease (COPD): a post hoc analysis of phase 3 trials. 3244

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Baseline anxiety independently predicts functional limitation and reduced health status in severe emphysema
Source: Annual Congress 2006 - Quality of life in various respiratory diseases
Year: 2006


Correlation between pulmonary function test (PFT) parameters and quality of life (QoL) and dyspnea in stable chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007



How to measure nutritional status before physical training in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 292s
Year: 2004

Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018

The impact of treatment of chronic obstructive pulmonary disease (COPD) on functional status and quality of life of patients
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012

Comparisons among various QOL assessments and clinical outcomes for one year in elderly patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 66s
Year: 2004

Baseline self-reported comorbidity in COPD patients referred for pulmonary rehabilitation (PR)
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006


Effects of the type of in-home caregiver on outcome in elderly chronic obstructive pulmonary disease (COPD) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 169s
Year: 2003

Does health status predict survival in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 203s
Year: 2002

The minimal important difference of exercise tests in severe COPD
Source: Eur Respir J 2011; 37: 784-790
Year: 2011



Analysis of the level of dyspnea and health-related quality of life (HRQoL) in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 250s
Year: 2002

An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 182s
Year: 2002

Does improvement in health status affect long term mortality in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 248s
Year: 2002

Long-term efficacy of repeated pulmonary rehabilitation programs (PRP) in chronic airway obstruction (CAO)
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


Repeated hospitalizations in patients and chronic respiratory failure due to COPD are best predicted by health status (QoL) and effort tolerance
Source: Eur Respir J 2003; 22: Suppl. 45, 575s
Year: 2003

Usefulness and relationship of clinical dyspnoea ratings with health status in chronic obstructive pulmonary disease patients
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Seasonal variations in exercise tolerance, activity and quality of life in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


Detection of acute health status deterioration among COPD patients by monitoring COPD assessment test score
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011


The availibility of copd assessment test (CAT) in determination of risk of early hospitalization in chronic obstructive pulmonary disease patients and its correlation with pulmonary function tests, dyspnea measurement scales and St George respiratory questionnaire
Source: International Congress 2014 – COPD markers
Year: 2014


Urban-rural differences in health status among patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011